Aurinia improved its commercial organization by appointing several vice presidents. This includes Chris Hayes (marketing), Fran Lynch (sales), Cara Felish (commercial operations), and Tim Hermes (market access). These individuals have proven experience in product launches related to therapies in nephrology and autoimmune diseases with experience at top companies such as AstraZeneca, Takeda Pharmaceutical, Mallinckrodt, and Ablynx (now Sanofi ). This will provide Aurinia Pharmaceuticals an opportunity to build its brand and bring awareness to the drug before launch.